Variable | AOR | 95Â % CI | P-value |
---|---|---|---|
Death | |||
 Level of consciousness at presentation (for a point increase in GCS) | 0.79 | 0.73–0.85 | <0.001 |
 Dexamethasone treatment | 3.38 | 1.87–6.12 | <0.001 |
 Aspiration pneumonia at presentation | 2.97 | 1.36–6.41 | 0.006 |
 Cranial nerve palsy at presentation | 4.73 | 1.45–15.50 | 0.010 |
Unfavorable outcome (GOS = 1–4) | |||
 Level of consciousness at presentation (for a point increase in GCS) | 0.77 | 0.66–0.89 | <0.001 |
 Dexamethasone treatment | 4.46 | 1.98–10.08 | <0.001 |
 TB suspected cases | 2.78 | 1.06–7.30 | 0.038 |
Neurologic sequelae | |||
 Focal neurologic deficit at presentation | 3.33 | 1.31–8.50 | 0.012 |
 Seizure at presentation | 2.20 | 1.03–4.67 | 0.041 |
 Duration of illness before presentation | 1.09 | 1.01–1.16 | 0.020 |
 Impaired consciousness (GCS < 15) | 2.65 | 1.21–5.81 | 0.015 |